AJP Legacy Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 206: 247-250, 1964;
0002-9513/64 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oppelt, W. W.
Right arrow Articles by Rall, D. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Oppelt, W. W.
Right arrow Articles by Rall, D. P.

Effect of certain drugs on cerebrospinal fluid production in the dog

W. W. Oppelt 1, C. S. Patlak 1, and D. P. Rall 1

1 Clinical Pharmacology and Experimental Therapeutics Service, National Cancer Institute, and Theoretical Statistics and Mathematics Section, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland

Cerebrospinal fluid (CSF) production rates were measured in the dog by ventriculocisternal perfusion with inulin containing buffer. Normal CSF production rate was found to be about 0.05 ml/min which represents a turnover of 0.4%/min. After intravenous administration of the carbonic anhydrase inhibitors, acetazolamide and methazolamide, a 40–50% decrease in CSF production occurred. An increase in plasma pCO2, by allowing the animals to inhale 95% oxygen, 5% CO2, did not result in any significant change in CSF production. Both intravenous and intrathecal administration of varying doses of the cardiac glycoside, ouabain, did not cause any significant change in CSF production rates. It is concluded that CSF production, in part, is controlled by a carbonic anhydrase system.

Key Words: carbonic anhydrase inhibitors • acetazolamide • methazolamide • cardiac glycosides • CSF production • effects of carbonic anhydrase inhibitors • CSF production • effects of cardiac glycosides • ventriculocisternal perfusion

Submitted on June 18, 1963




This article has been cited by other articles:


Home page
Palliat MedHome page
S. Kirkham
The palliation of cerebral tumours with high-dose dexamethasone: a review
Palliative Medicine, January 1, 1988; 2(1): 27 - 33.
[Abstract] [PDF]


Home page
Arch NeurolHome page
A. C. Mancall, G. J. DiGregorio, C. B. Brill, and E. Ruch
The Effect of {bigtriangleup}-9-Tetrahydrocannabinol on Rat Cerebrospinal Fluid
Arch Neurol, November 1, 1985; 42(11): 1069 - 1071.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. H. Weiss and N. Wertman
Modulation of CSF Production by Alterations in Cerebral Perfusion Pressure
Arch Neurol, August 1, 1978; 35(8): 527 - 529.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1964 by the American Physiological Society.